Skip to content

Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery

Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01428830
Enrollment
524
Registered
2011-09-05
Start date
2012-01-31
Completion date
2013-08-31
Last updated
2015-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal Fistula

Keywords

fistula, catheter, surgery, obstetrics, gynecology, urology

Brief summary

This facility-based, multi-center randomized controlled trial (RCT) will test the non-inferiority of short-term (7 day) urethral catheterization compared to longer-term (14 day) urethral catheterization in terms of predicting fistula repair breakdown three months following urinary fistula repair surgery. The study will be conducted among 507 women with simple fistula presenting at 8 study sites in Sub-Saharan Africa for fistula repair surgery.

Detailed description

A vaginal fistula is a devastating condition, affecting an estimated 2 million girls and women across Africa and Asia. Finding ways of providing services in a more efficient and cost-effective manner, without compromising surgical outcomes and the overall health of the patient, is paramount. Shortening the duration of urethral catheterization following fistula repair surgery would increase treatment capacity (by freeing available bed space and increasing availability of nursing staff), lower costs of services, and potentially lower risk of healthcare-associated infections among fistula patients. There is a lack of empirical evidence supporting any particular length of time for urethral catheterization following fistula repair surgery. This facility-based, multi-center randomized controlled trial (RCT) will test the non-inferiority of short-term (7 day) urethral catheterization compared to longer-term (14 day) urethral catheterization in terms of predicting fistula repair breakdown. The primary outcome is fistula repair breakdown three months following fistula repair surgery as assessed by a urinary dye test, a routine practice in fistula repair services. t. Secondary outcomes will include repair breakdown one week following catheter removal, intermittent catheterization due to urinary retention and the occurrence of septic or febrile episodes, prolonged hospitalization (defined as a stay at the facility beyond one week following initial catheter removal related to an adverse event), catheter blockage, and self-reported residual incontinence. This study will be conducted among 507 women with simple fistula presenting at 8 study sites for fistula repair surgery over the course of 16-18 months at each site.

Interventions

PROCEDURE7-day catheterization following fistula repair surgery

This group will have an indwelling urethral catheter for 7 days following fistula repair surgery.

PROCEDURE14 day catheterization

This group will have an indwelling urethral catheter for 14 days following fistula repair surgery.

Sponsors

World Health Organization
CollaboratorOTHER
United States Agency for International Development (USAID)
CollaboratorFED
EngenderHealth
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Have a simple fistula, as determined at the end of fistula repair surgery (irrespective of the number of prior repair attempts and the cause of the fistula, with the exceptions noted under the

Exclusion criteria

below) * Have a closed fistula at completion of surgery * Have a closed fistula 7 days after surgery (i.e. at the time of randomization) * Understand study procedures and requirements * Agree to return to the facility for one follow-up visit three month after the date of surgery * Provide informed consent to participate in the study or in the case of non-emancipated minors, both consent to the study and receive proxy consent to participate in the study * Have no contraindications precluding their participation.

Design outcomes

Primary

MeasureTime frame
Fistula repair breakdown three months following fistula repair surgery as assessed by a urinary dye test.3 months

Secondary

MeasureTime frame
Intermittent catheterization due to urinary retention7 or 14 days post repair
Prolonged hospitalization14 or 21 days post-repair
Repair breakdown one week following catheter removal14 days or 21 days post-repair
Self-reported residual incontinence3 months
The occurrence of septic or febrile episodes14 or 21 days post-repair
Catheter blockage14 or 21 days post repair

Countries

Democratic Republic of the Congo, Ethiopia, Guinea, Kenya, Niger, Nigeria, Sierra Leone, Uganda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026